Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer

Cancer Gene Therapy, Published online: 09 November 2022; doi:10.1038/s41417-022-00543-5Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer

Source: Cancer Gene Therapy - November 9, 2022 Category: Cancer & Oncology Authors: Shaochuan Liu Yuan Meng Liang Liu Yingge Lv Feng Wei Wenwen Yu Limei Wang Xiying Zhang Xiubao Ren Qian Sun Source Type: research